Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Receivables - Other (2017 - 2024)

Historic Receivables - Other for ProPhase Labs (PRPH) over the last 7 years, with Q3 2024 value amounting to $593000.0.

  • ProPhase Labs' Receivables - Other changed N/A to $593000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $593000.0, marking a year-over-year change of. This contributed to the annual value of $250000.0 for FY2022, which is 0.0% changed from last year.
  • Latest data reveals that ProPhase Labs reported Receivables - Other of $593000.0 as of Q3 2024.
  • In the past 5 years, ProPhase Labs' Receivables - Other registered a high of $14.9 million during Q1 2022, and its lowest value of $250000.0 during Q4 2021.
  • For the 4-year period, ProPhase Labs' Receivables - Other averaged around $4.0 million, with its median value being $3.7 million (2020).
  • Per our database at Business Quant, ProPhase Labs' Receivables - Other plummeted by 7942.39% in 2021 and then surged by 95040.0% in 2022.
  • Quarter analysis of 4 years shows ProPhase Labs' Receivables - Other stood at $1.2 million in 2020, then tumbled by 79.42% to $250000.0 in 2021, then soared by 950.4% to $2.6 million in 2022, then crashed by 77.42% to $593000.0 in 2024.
  • Its Receivables - Other stands at $593000.0 for Q3 2024, versus $585000.0 for Q2 2024 and $561000.0 for Q1 2024.